Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Currys shares surge after profit upgrade

(Sharecast News) - Shares in Currys surged on Thursday as the electrical retailer lifted annual earnings guidance after "robust" trading since the start of the year, including a return to growth at its troubled Nordics division.

Group adjusted profit before tax is now expected to be around £160m, compared to previous guidance of £145-155m, Currys said with less than five weeks of the financial year remaining, adding that like-for-like sales growth in the UK & Ireland and the Nordics continued to be positive.

The group also expects to finish the year in a strong net cash position. Currys shares were up more than 16% in London trade.

Analysts at Shore Capital said the Nordic market had been a "drag on group sales for the past three years, so it is highly encouraging to see this region return to growth".

"The share price looks undemanding to us, if Currys can continue to deliver on LFL growth across its markets then we would expect a re-rating of the stock."

AJ Bell investment director Russ Mould said: "Currys is one of the last remaining electronics retailers with a physical presence on the high street and it is making a virtue of this status by offering handholding when people are buying increasingly complex consumer technology."

"It also offers a full range of services from credit to delivery, installation, repairs and recycling, and these help it to stand out from the crowd.

"A notable feature of Currys' recent performance is the strong cash flow which puts the company in an enviable position relative to other retailers. It potentially allows Currys to go from being prey to predator in the sector, should it spy the right opportunity."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.